These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 8212613)

  • 1. Multidimensional assessment of voice quality after injection augmentation of the vocal fold with autologous adipose tissue or calcium hydroxylapatite.
    Mes SD; Smajlović E; Heijnen BJ; Hendriksma M; Jansen JC; Langeveld APM; Sjögren EV
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):1967-1978. PubMed ID: 34846572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis.
    Bignamini AA; Chebil A; Gambaro G; Matuška J
    Adv Ther; 2021 Mar; 38(3):1483-1513. PubMed ID: 33502688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sulodexide in patients with peripheral vascular disease.
    Lasierra-Cirujeda J; Coronel P; Aza M; Gimeno M
    J Blood Med; 2010; 1():105-15. PubMed ID: 22282689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Młynarski J; Strugala M
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):708-10. PubMed ID: 1669138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of sulodexide in the prevention of obliterative atherosclerotic arterial disease of the lower limbs].
    Martino R; Benini D
    Clin Ter; 1985 Mar; 112(5):429-37. PubMed ID: 4017468
    [No Abstract]   [Full Text] [Related]  

  • 7. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
    Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
    Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
    Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
    Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J
    Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of high risk patients with diabetes mellitus].
    Krone W; Müller-Wieland D
    Verh Dtsch Ges Inn Med; 1991; 97():238-42. PubMed ID: 1808892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of hemorrheological drugs in microcirculatory ischemia].
    Avellone G; Di Garbo V; Panno AV; Longo B; Accardo MA; Strano A
    Clin Ter; 1987 Jul; 122(2):121-7. PubMed ID: 2973901
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulodexide: a renewed interest in this glycosaminoglycan.
    Lauver DA; Lucchesi BR
    Cardiovasc Drug Rev; 2006; 24(3-4):214-26. PubMed ID: 17214598
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.